BPA Call 75N91020A00003-75N91021F00004
Award Date 9/24/21
Potential Completion Date 9/23/22
Potential Value $173K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies will...
- This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...
- This is a firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract provides the National Institutes of Health's (NIH) National Cancer Institute with access to the UK Clinical Practice Research Datalink (CPRD) database of de-identified patient data, as well as linkages to other registries, to support the agency's epidemiological...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price contract valued at fifteen thousand two hundred eighty-one dollars to the Department of Health Medicines & Healthcare Products Regulatory Agency. The contract calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study the relationship between hormone therapy and risks of secondary...
- This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract, valued at $2,816,500.00, is for the recompete of the General Practice Research Division within the MHRA. It is a firm fixed price contract with no set-aside designation. The contract provides access to the Clinical Practice Research Datalink (CPRD) database and...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,571.47 firm fixed price call against a blanket purchase agreement to the Medicines & Healthcare Products Regulatory Agency, doing business as the Department of Health, located in Great Britain, United Kingdom. The contract is for regulatory services to be delivered by September 22, 2021 in support of the National Cancer Institute's research efforts. No set aside designation...
- The National Cancer Institute (NCI), a civilian agency, awarded Bionexus Incorporated a Blanket Purchase Agreement (BPA) call valued at $4,460 on December 4, 2012, under solicitation POTS 13-012515. The contract was structured as a firm fixed-price arrangement with no set-aside designation. Performance was to be completed by December 10, 2012, at the NCI's facility in Bethesda, Maryland. This BPA call represents a task order or delivery order placed against an existing blanket purchase agreement...
- <p>This is a firm-fixed price purchase order award by the National Institutes of Health (NIH), National Cancer Institute, to the Medicines and Healthcare Products Regulatory Agency. The award, valued at $55,960.57, is for payment related to a prior award with contract number 75N91020A00003. The period of performance runs through July 23, 2024. This award does not have a set-aside designation.</p>
- The National Cancer Institute, a civilian agency, awarded a Blanket Purchase Agreement (BPA) call contract to C.A.S.E.T. Associates, LTD. (UEI: CVHFDB52ZZ76) on May 12, 2016, with a ceiling value of $9,120.00. This firm fixed-price contract was executed without a set-aside designation and is scheduled for ultimate completion on May 17, 2016. The place of performance is located in Bethesda, Maryland, which serves as the headquarters for the National Cancer Institute. As a BPA call, this...
- This firm fixed-price purchase order, valued at $68,640, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health within the Department of Health and Human Services, to Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, doing business as Stichting NKI-AVL. Under this contract, the contractor will collect, harmonize, and manage clinical trial data being contributed to the Confluence Project from European clinical trials. The...